IL6 and gastric cancer: Existing clinical studies have shown that peripheral blood of gastric cancer patients showed a significant increase in serum pepsinogen, IL-6, which was correlated with tumor diameter and highly pelvic lymph node metastasis in gastric cancer patients, which is considered a factor associated with gastric cancer development and prognosis.